MCRIP2

Across TCGA pan-cancer cohorts, MCRIP2 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MCRIP2 data layer compared with 28 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MCRIP2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MCRIP2 expression acts as an unfavorable survival marker.

KIRC and LIHC are the cancer types where MCRIP2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.167	0.655	.038	12	view →
LIHC	OS	Median	All	0.167	0.688	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MCRIP2–KIRC (OS)

Open the KIRC breakdown →